Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OraSure Technologies Inc (NASDAQ:OSUR)

Delayed Data
As of Dec 02
 -0.18 / -2.11%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

OraSure Technologies, Inc. engages in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies, as well as other diagnostic products. It operates through two segments: OraSure and DNAG. OraSure segment consists of development, manufacture and sale of oral fluid diagnostic products and specimen collection devices and the manufacture and sale of medical devices used for the removal of benign skin lesions by cryosurgery. DNAG segment is newly acquired subsidiary of the company, which is based in Ottawa, Canada and manufactures and sells oral fluid collection devices that are used to collect samples of genetic material for molecular testing. OraSure Technologies was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Contact Information

OraSure Technologies, Inc.
220 East 1st Street
Bethlehem Pennsylvania 18015
P:(610) 882-1820
Investor Relations:



Other institutional44.17%
Mutual fund holders39.88%
Individual stakeholders10.11%

Top Executives

Douglas A. MichelsPresident, Chief Executive Officer & Director
Ronald H. SpairDirector, Chief Operating & Financial Officer
Michael ReedChief Science Officer, SVP-Research & Development
Mark L. KunaSenior Vice President & Controller
Jack E. JerrettSecretary, Senior Vice President & General Counsel